ADC Drug Products: Solutions to Manage Risks and Enhance Stability - Stevanato Group

Discover how Stevanato Group integrated solutions address the most critical challenges in handling Antibody Drug Conjugates (ADCs). Watch the Webinar.

Stevanato Group | Pharma & Biotech Integrated Solutions - Stevanato Group > News & Events - Stevanato Group > Webinars - Stevanato Group - Stevanato Group > ADC Drug Products: Solutions to Manage Risks and Enhance Stability - Stevanato Group

page-wrapper

WEBINAR

ADC Drug Products: Solutions to Manage Risks and Enhance Stability

April 30, 2026

vials amber ldp

Abstract

Discover in this webinar how Stevanato Group integrated solutions address the most critical challenges in handling Antibody Drug Conjugates (ADCs) across both liquid and lyophilized presentations. The session will explore vial packaging solutions, multi-analytical approaches for container surface evaluation, and advanced inspection technologies - all designed to enhance product stability, minimize risk, and ensure operator safety.

Addressed Challenges:

Prevent fogging and breakages with optimized packaging and gentle handling solutions for lyophilized ADCs
Reduce delamination and light sensitivity risks with specialized LDP and amber glass vials for liquid ADCs
Ensure consistent container performance and minimize drug-container interaction through advanced surface characterization and analytical services.
Ensure reliable inspection and minimize rejection with automated vision inspection platforms.

Learning Objectives:

Explore Stevanato Group's vial solutions tailored to ADC needs. Fina^®, Nexa^®, LDP, and amber vials to protect your product and to optimize manufacturing processes, and fill and finish operations.
Discover CVT Core and VRU automated vision inspection systems to protect both product quality and operator safety.
Learn how Stevanato Group’s Technology Excellence Centers (TEC) provide multi-analytical approaches to support risk assessment and product stability.